scout
|Videos|October 13, 2016

An Overview of the MERIBEL Study in HER2-Negative Breast Cancer

Antonio Llombart-Cussac, MD, PhD, medical oncologist, chairman, Medical Oncology Service, University Hospital Arnau de Vilanova in Valencia, Spain, discusses the MERIBEL study during an interview at the 2016 ESMO Congress.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME